Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
CYR61, Migrasomes, and Irradiated BMSC Repair
2026-10-06
A 2025 study links CYR61, integrin αvβ3–ERK signaling, and migrasomes to the recovery of migration and osteoblastic differentiation in irradiated bone marrow mesenchymal stem cells. The findings offer a mechanistic framework for osteoradionecrosis research, while remaining limited to an in vitro cellular model and requiring validation in more complex systems.
Bismuth Subsalicylate: Readouts That Matter
2026-10-06
Bismuth Subsalicylate research is strongest when prostaglandin biology, inflammatory phenotypes, and cell-state readouts are interpreted together. This article develops an evidence-centered framework using annexin V research to clarify what membrane changes can—and cannot—show in gastrointestinal disorder studies.
NFIA Coordinates Bone Formation and Resorption
2026-10-05
A 2026 Genes & Diseases study identifies nuclear factor I/A (NFIA) as a context-dependent regulator of bone homeostasis in mesenchymal stem and progenitor cells. By controlling stromal RANKL and SFRP1 expression, NFIA restrains osteoclast support while also limiting osteoblast differentiation, with loss of resorption control dominating the resulting bone-loss phenotype.
PBS (Phosphate-Buffered Saline) Overview
2026-10-05
APExBIO PBS, SKU K2818, is described as a sterile, ready-to-use phosphate-buffered saline solution for routine laboratory handling. No matched paper evidence was provided, so performance and assay compatibility cannot be independently assessed.
Prion Self-Assembly and Adaptive Mutagenesis
2026-10-04
A 2026 Cell study reports that prion-based protein self-assembly can reversibly and heritably tune DNA mutagenesis in yeast, reshaping adaptation under strong selection. The work links protein-state inheritance with genome stability and drug-resistance trajectories while highlighting important limits on extrapolation to clinical biology.
RG108: Evidence, Mechanism, Scope, and Limits
2026-10-03
RG108 is described by APExBIO as a small-molecule DNA methyltransferase inhibitor, but the supplied evidence is mainly a product description rather than an independent, peer-reviewed evaluation. This overview explains what the mechanism may support, why biochemical potency does not establish cellular or clinical efficacy, and why findings from a separate 6-thioguanine study should not be attributed to RG108.
Dual-Action Inhibitors Reprogram p38α Dephosphorylation
2026-10-02
The reference study shows that selected kinase inhibitors can do more than block p38α catalysis: they also accelerate WIP1-mediated dephosphorylation by stabilizing a phosphatase-accessible activation-loop conformation. This structure-guided mechanism provides a framework for designing inhibitors that combine active-site blockade with faster kinase deactivation, while leaving disease-model translation to future studies.
CUDC-907: Practical PI3K/HDAC Workflow Guide
2026-10-01
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, chromatin-associated responses, cell-cycle distribution, and apoptosis. This dossier-based guide provides starting conditions and QC checks, while emphasizing that the compound is for scientific research only and is not validated for diagnosis, treatment, or clinical decision-making.
Toremifene in Reliable Prostate Cancer Assays
2026-10-01
This scenario-based guide explains how Toremifene (SKU A3884) can support controlled hormone-responsive cancer experiments, from stock preparation through interpretation of cell-growth data. It connects the reported Toremifene IC50 of approximately 1 ± 0.3 μM with practical assay design while distinguishing estrogen-receptor research from emerging STIM1–TSPAN18 metastasis biology.
γH2AX DNA Damage Detection Kit: Practical Guide
2026-09-30
Learn how γH2AX immunofluorescence can resolve ambiguous viability, cytotoxicity, and DNA repair results. This scenario-based guide explains when the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), SKU K2275, is a practical choice for reproducible DSB assessment.
ECL Chemiluminescent Substrate Detection Kit Guide
2026-09-30
The ECL Chemiluminescent Substrate Detection Kit (Enhanced) supports sensitive HRP-based western blot detection when low-abundance proteins, prolonged signal capture, or multiple imaging platforms are required. It is intended for protein immunodetection workflows using HRP-labeled antibodies and should not be treated as a universal reagent for non-HRP assays or as a substitute for assay-specific validation.
Nuclear cGAS Restricts LINE-1 Retrotransposition
2026-09-29
The reference study identifies a nuclear cGAS–CHK2–TRIM41 pathway that limits LINE-1 retrotransposition by promoting ubiquitination and degradation of ORF2p. Its findings connect DNA damage signaling with posttranslational control of mobile genetic elements, providing a mechanistic framework for genome-integrity and cancer research.
Topotecan: Pharmacology, Mechanism, and Clinical Evidence
2026-09-29
The reference review established Topotecan as a water-soluble, semisynthetic camptothecin analogue whose clinical activity derives from stabilization of the DNA–topoisomerase I cleavable complex. It connected molecular pharmacology with pharmacokinetics, dose-limiting toxicity, and early evidence in ovarian cancer, small cell lung cancer, and other tumors, while identifying renal dosing and schedule optimization as important translational issues.
Sulfo-NHS-SS-Biotin for Cell-Surface Proteomics
2026-09-28
Sulfo-NHS-SS-Biotin enables water-compatible, reversible labeling of cell-surface proteins and purified biomolecules. This article explains how its disulfide-cleavable design can test, rather than merely describe, glycoRNA–RBP surface domains identified in recent research.
HyperFluor 488 Goat Anti-Rabbit IgG: Workflow Guide
2026-09-28
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody is a fluorescent secondary reagent for visualizing rabbit primary antibodies in fluorescence-based assays. Use it with compatible rabbit primaries and assay-specific controls; do not assume a universal working dilution or validated performance in every tissue, cell type, or multiplex panel.
8169 records 6/545 page Previous Next First page 上5页 678910 下5页 Last page